Tactile Systems Technology Inc

TCMDNASDAQ · USD
22.31USD-0.51 (-2.24%)
8810

Tactile Systems Technology Inc (TCMD) Covered Calls

As of September 28, 2026, TCMD has 4 covered call opportunities in the coming three months. Return ranges from 12.8 to 33.5% until expiration. Annualized return ranges from 29.8 to 92.3%. The nearest expiration is November 20, 2026. Maximum potential profit is $762.

Read more

Running TCMD covered calls helps you generate consistent income from Tactile Systems Technology Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Tactile Systems Technology Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best TCMD covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if TCMD stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling TCMD covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Tactile Systems Technology Inc covered call is worth writing.

Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders.

The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Income-focused investors, long-term TCMD holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling TCMD covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Tactile Systems Technology Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryMedical Devices
  • SectorHealthcare
  • IV percentile64.29% Neutral
  • Market cap (M$)517
  • 52 weeks high-39.58%
  • 52 weeks low69.29%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$39.00
    74.81% above the current stock price
  • Dividend—
  • Payout ratio0.00%
  • Earnings date2026-11-02
  • P/E21.02
  • Future P/E14.88
  • EPS (ttm)1.09
  • EPS growth next 5 years37.89%

As of September 28, 2026

2026-11-205625.009.990.951.95322.0014.1792.33-4.18+0.4121.00
2027-04-1620330.0031.980.354.10762.0033.5260.28-1.54+0.3813.75
2027-01-1511225.009.990.653.40292.0012.8541.87-2.86+0.45152.75
2027-04-1620325.009.991.505.50377.0016.5929.82-6.60+0.5344.00

As of September 28, 2026

Sell covered calls with the data behind you

Find the best TCMD covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial